annual cash & cash equivalents:
$287.08M+$21.37M(+8.04%)Summary
- As of today (September 15, 2025), COGT annual cash & cash equivalents is $287.08 million, with the most recent change of +$21.37 million (+8.04%) on December 31, 2024.
- During the last 3 years, COGT annual cash & cash equivalents has risen by +$67.39 million (+30.68%).
- COGT annual cash & cash equivalents is now at all-time high.
Performance
COGT Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$237.85M-$7.81M(-3.18%)Summary
- As of today (September 15, 2025), COGT quarterly cash & cash equivalents is $237.85 million, with the most recent change of -$7.81 million (-3.18%) on June 30, 2025.
- Over the past year, COGT quarterly cash & cash equivalents has dropped by -$125.37 million (-34.52%).
- COGT quarterly cash & cash equivalents is now -45.42% below its all-time high of $435.74 million, reached on March 31, 2024.
Performance
COGT quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
COGT Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.0% | -34.5% |
| 3 y3 years | +30.7% | -27.2% |
| 5 y5 years | +667.1% | +1014.5% |
COGT Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +30.7% | -45.4% | +7.4% |
| 5 y | 5-year | at high | +667.1% | -45.4% | +1014.5% |
| alltime | all time | at high | +667.1% | -45.4% | +1014.5% |
COGT Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $237.85M(-3.2%) |
| Mar 2025 | - | $245.66M(-14.4%) |
| Dec 2024 | $287.08M(+8.0%) | $287.08M(-14.4%) |
| Sep 2024 | - | $335.52M(-7.6%) |
| Jun 2024 | - | $363.22M(-16.6%) |
| Mar 2024 | - | $435.74M(+64.0%) |
| Dec 2023 | $265.71M(+2.0%) | $265.71M(-4.8%) |
| Sep 2023 | - | $279.04M(-15.3%) |
| Jun 2023 | - | $329.40M(+48.7%) |
| Mar 2023 | - | $221.52M(-15.0%) |
| Dec 2022 | $260.53M(+18.6%) | $260.53M(-10.3%) |
| Sep 2022 | - | $290.35M(-11.2%) |
| Jun 2022 | - | $326.82M(+71.1%) |
| Mar 2022 | - | $191.05M(-13.0%) |
| Dec 2021 | $219.68M | $219.68M(+8.3%) |
| Sep 2021 | - | $202.89M(-7.0%) |
| Jun 2021 | - | $218.10M(-5.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $230.74M(-4.7%) |
| Dec 2020 | $242.19M(+547.2%) | $242.19M(+87.1%) |
| Sep 2020 | - | $129.42M(+506.4%) |
| Jun 2020 | - | $21.34M(-27.9%) |
| Mar 2020 | - | $29.60M(-20.9%) |
| Dec 2019 | $37.42M(-52.4%) | $37.42M(-18.4%) |
| Sep 2019 | - | $45.88M(-17.9%) |
| Jun 2019 | - | $55.86M(-16.8%) |
| Mar 2019 | - | $67.10M(-14.6%) |
| Dec 2018 | $78.59M(+91.5%) | $78.59M(-9.8%) |
| Sep 2018 | - | $87.12M(-7.8%) |
| Jun 2018 | - | $94.50M(+191.2%) |
| Mar 2018 | - | $32.45M(-20.9%) |
| Dec 2017 | $41.04M(-40.1%) | $41.04M(-15.2%) |
| Sep 2017 | - | $48.38M |
| Dec 2016 | $68.51M(-24.3%) | - |
| Dec 2015 | $90.48M | - |
FAQ
- What is Cogent Biosciences, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Cogent Biosciences, Inc.?
- What is Cogent Biosciences, Inc. annual cash & cash equivalents year-on-year change?
- What is Cogent Biosciences, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Cogent Biosciences, Inc.?
- What is Cogent Biosciences, Inc. quarterly cash & cash equivalents year-on-year change?
What is Cogent Biosciences, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of COGT is $287.08M
What is the all time high annual cash & cash equivalents for Cogent Biosciences, Inc.?
Cogent Biosciences, Inc. all-time high annual cash & cash equivalents is $287.08M
What is Cogent Biosciences, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, COGT annual cash & cash equivalents has changed by +$21.37M (+8.04%)
What is Cogent Biosciences, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of COGT is $237.85M
What is the all time high quarterly cash & cash equivalents for Cogent Biosciences, Inc.?
Cogent Biosciences, Inc. all-time high quarterly cash & cash equivalents is $435.74M
What is Cogent Biosciences, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, COGT quarterly cash & cash equivalents has changed by -$125.37M (-34.52%)